Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Terra Venture Partners
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Salvia BioElectronics11-50 employees
Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is…
Slate MedicinesSeries A $130M · 8 mo ago · Founded 2024 · 51-200 employees
We’re building a pipeline of next-generation therapeutics focused on broadening the treatment paradigm for migraine and other headache…
NeurocarrusFounded 2017 · 11-50 employees
What is Neurocarrus?Treating Neurodegenerative Disease and Pain Without Addiction.Neurocarrus is a biotech company developing a novel drug…
Damona PharmaceuticalsSeed $5.5M · 4 yr ago · 51-200 employees
Damona Pharmaceuticals is developing precision neuromedicines to reverse cognitive deficits associated with brain disorders.associated with…
OrthoPulse® is the first and only approved medical device that uses near infrared light technology to shorten treatment time and reduce…
Neuros MedicalSeries D $56M · 15 mo ago
Who We Are Giving patients the ability to gain power over pain About Neuros There are nearly two million amputees in the U.S., with 185,000…

Overview

THE POWER OF MIGRAINE RELIEF IS ELECTRIC Relivion is the first and only wearable, at-home therapy to stimulate the 2 major nerve pathways associated with migraine pain.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
34 portfolio companies: StartupHub.ai, Israelhayom, SOME FACTS AB and 31 more

News

Blog 1 year ago
Why Neuromodulation Could Be the Future of Migraine Treatment
For decades, migraine treatment has followed the same predictable script: medications to stop attacks, medications to prevent them, and (if those fail) more medications to manage the side effects of the first ones. The market is dominated by triptans, CGR
Read more
Report
Blog 1 year ago
Could Relivion Cut Migraine's Multi-Billion Dollar Burden?
A Closer Look at Cost Savings and Healthcare EconomicsMigraine isn't just a headache-it's a multi-billion dollar drain on healthcare systems and economies worldwide. In the U.S. alone, migraine costs are estimated at over $36 billion annually (1), driven
Read more
Report
Blog 1 year ago
How Big Is the Migraine Market in the United States?
How Big Is the Migraine Market in the United States? If you've ever had a migraine, you know it's not just a bad headache. It's a full-body shutdown-pounding pain, nausea, light and sound sensitivity, sometimes even vision loss. It can wreck your whole da
Read more
Report
News menafn 3 years ago
Neurolief Launches A New U.S. Telehealth Channel Increasing Patient Access To The Relivion MG Migraine Therapy
Neurolief Launches A New U.S. Telehealth Channel Increasing Patient Access To The Relivion MG Migraine Therapy. TAMPA, Fla., March 1, 2023 /PRNewswire/ -- Neurolief, a medical neurotechnology company, announces the launch of a new Telehealth Channel to en
Read more
Report